Your trusted health, nutrition, and personalized lifestyle medicine resource

Advancing Periodontal Disease Treatment with Nutraceuticals and Inflammation Control


In this interview, Thomas Van Dyke, DDS, PhD talks about the current role of nutraceuticals in managing inflammation associated with periodontal disease. He elaborates on the use of Omega-3s derivatives such as specialized pro-resolving mediators (SPMs) as an adjunctive therapy in periodontal disease. Additionally, Dr. Van Dyke explains the connection between periodontal infections and increased risk of cardiovascular incidents, emphasizing the advantages of controlling inflammation. He concludes by discussing his ongoing research on using lipoxins and resolvins for the treatment and prevention of periodontal disease.

Thomas Van Dyke, DDS, PhD, is the VP of Clinical and Translational Research at the Forsyth Institute. He is a Professor in Oral Medicine, Infection, and Immunity, at Harvard University.

From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

Sponsored by
© 2024 Metagenics Institute. All Rights Reserved